Cipla Ltd.
BSE: 500087 | Sector: Health care |
NSE: CIPLA | ISIN Code: INE059A01026 |
BSE 14:26 | 30 Jan | 1036.35 |
-10.70 (-1.02%) |
OPEN
1047.10 |
HIGH
1055.00 |
LOW
1029.00 |
NSE 14:19 | 30 Jan | 1037.45 |
-9.80 (-0.94%) |
OPEN
1057.00 |
HIGH
1057.00 |
LOW
1028.50 |
OPEN | 1047.10 |
PREVIOUS CLOSE | 1047.05 |
VOLUME | 12468 |
52-Week high | 1185.20 |
52-Week low | 880.00 |
P/E | 30.23 |
Mkt Cap.(Rs cr) | 83,649 |
Buy Price | 1037.30 |
Buy Qty | 5.00 |
Sell Price | 1038.30 |
Sell Qty | 23.00 |
About Cipla Ltd.
Cipla Ltd is one of the leading pharmaceutical companies in India. The company focuses on development of new formulations and has a wide range of pharmaceutical products. The product portfolio includes over 1500 products across wide range of therapeutic categories.Cipla Ltd was incorporated in the year 1935 with the name Chemical Industrial & Pharmaceutical Laboratories Ltd. Khwaja Abdul Hamied th...> More
Cipla Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | ( cr) | 83,649 | |
EPS - TTM | () | [*S] | 34.28 |
P/E Ratio | (X) | [*S] | 30.23 |
Face Value | () | 2 | |
Latest Dividend | (%) | 250.00 | |
Latest Dividend Date | 08 Aug 2022 | ||
Dividend Yield | (%) | 0.48 | |
Book Value / Share | () | [*S] | 291.76 |
P/B Ratio | () | [*S] | 3.55 |
News
-
Cipla Q3 net up 10% to Rs 801 cr, posts highest ever quarterly sales in US
-
Cipla launches diagnostic device, says it will provide results in minutes
-
Stocks to Watch: Elin Electronics, Cipla, Eicher Motors, RIL, Banks, Pharma
-
Pharma stocks upbeat amid Covid-19 scare; Divi's, Lupin can gain up to 10%
-
Cipla Q2 PAT up 11% PAT to Rs 789 cr on strong Covid-adjusted growth rate
Announcement
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Announcement under Regulation 30 (LODR)-Investor Presentation
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
-
Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended 31St
Cipla Ltd - Financial Results
Particulars ( cr) | Dec 2022 | Dec 2021 | % Chg |
Net Sales | 5810.09 | 5478.86 | 6.05 |
Other Income | 114.44 | 91.29 | 25.36 |
Total Income | 5924.53 | 5570.15 | 6.36 |
Total Expenses | 4402.54 | 4247.89 | 3.64 |
Operating Profit | 1521.99 | 1322.26 | 15.11 |
Net Profit | 808.05 | 758.95 | 6.47 |
Equity Capital | 161.43 | 161.36 | - |
Cipla Ltd - Peer Group
Company | Price() | Chg (%) | Mkt Cap ( CR) |
Sun Pharma.Inds. | 1047.70 | 0.39 | 251374.65 |
Divi's Lab. | 3370.35 | -0.45 | 89465.94 |
Cipla | 1036.35 | -1.02 | 83648.99 |
Dr Reddy's Labs | 4315.00 | -0.08 | 71853.38 |
Torrent Pharma. | 1540.10 | 0.15 | 52123.14 |
Abbott India | 21049.10 | -0.80 | 44729.34 |
Cipla Ltd - SHAREHOLDING PATTERN
|
|
Cipla Ltd - Research Reports
Cipla Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | -2.47% | -2.36% | -2.95% | -3.27% |
1 Month | -3.60% | -3.58% | -2.78% | -3.20% |
3 Month | -10.27% | -10.19% | -1.36% | -1.47% |
6 Month | 5.95% | 6.14% | 2.74% | 2.14% |
1 Year | 11.18% | 11.28% | 3.40% | 2.48% |
3 Year | 129.53% | 130.03% | 44.56% | 45.61% |
Cipla Ltd - STOCK STRENGTH
Today's Low/High | 1029.00 | 1055.00 | |
Week Low/High | 1020.45 | 1075.00 | |
Month Low/High | 1020.45 | 1097.00 | |
YEAR Low/High | 880.00 | 1185.00 | |
All TIME Low/High | 0.61 | 1185.00 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices